Stay updated on Risankizumab in PsA Patients: Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in PsA Patients: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the Study Details page content and layout appear unchanged.
    Difference
    0.1%
    Check dated 2025-11-01T20:32:48.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Summary of changes: added a government operating-status notice and a new 196-week clinical trial publication citation, and updated the software version from v3.1.0 to v3.2.0; the prior version tag v3.1.0 was removed.
    Difference
    2%
    Check dated 2025-10-04T00:45:15.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page updates to Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content.
    Difference
    0.1%
    Check dated 2025-09-26T18:09:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Standardizes location naming from ‘Tatarstan Republic’ to ‘Tatarstan, Respublika’ and from ‘Tatarstan Republic, Russia’ to ‘Tatarstan, Respublika, Russia’ for the Kazan address.
    Difference
    0.1%
    Check dated 2025-09-19T12:35:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and the Back to Top element was removed; core content, pricing, stock, and time-slot information remain unchanged.
    Difference
    0.1%
    Check dated 2025-09-12T08:43:27.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-05T03:59:08.000Z thumbnail image

Stay in the know with updates to Risankizumab in PsA Patients: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in PsA Patients: Clinical Trial page.